ADC Therapeutics SA (ADCT) — Financial Flexibility Index
ADC Therapeutics SA (ADCT) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-29.68 Million (operating CF $-29.71 Million minus capex $32.00K) represents 0% of total liabilities ($507.87 Million). Check cash flow reinvestment rate of ADC Therapeutics SA to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
ADC Therapeutics SA Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for ADC Therapeutics SA across 9 annual periods. For the full cash flow conversion analysis, see ADC Therapeutics SA (ADCT) cash conversion ratio.
Annual Financial Flexibility Index for ADC Therapeutics SA (2017–2025)
Year-by-year free cash flow to debt coverage for ADC Therapeutics SA. Explore debt repayment capacity of ADC Therapeutics SA to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.28x | $-140.91 Million | $-141.17 Million | $508.98 Million | ▼ -18.1% |
| 2024 | -0.23x | $-122.97 Million | $-123.83 Million | $524.62 Million | ▼ -2.1% |
| 2023 | -0.23x | $-115.47 Million | $-118.69 Million | $503.03 Million | ▲ +31.4% |
| 2022 | -0.33x | $-137.62 Million | $-138.31 Million | $411.41 Million | ▲ +33.4% |
| 2021 | -0.50x | $-227.00 Million | $-233.38 Million | $451.88 Million | ▲ +46.1% |
| 2020 | -0.93x | $-165.92 Million | $-168.73 Million | $178.19 Million | ▲ +79.3% |
| 2019 | -4.50x | $-119.43 Million | $-121.58 Million | $26.53 Million | ▲ +7.9% |
| 2018 | -4.89x | $-118.89 Million | $-121.36 Million | $24.32 Million | ▼ -55.2% |
| 2017 | -3.15x | $-71.79 Million | $-74.94 Million | $22.78 Million | — |